Cincinnati Financial Corporation's Q2 2025 results reveal strong premium growth and margin expansion, supporting steady stock performance and a moderate buy analyst rating.

SelectQuote faces DOJ and class-action lawsuits over alleged deceptive Medicare Advantage sales practices, impacting stock prices and raising compliance concerns.

Q2 earnings for leading U.S. insurance companies reveal mixed financial results amid stable market conditions and evolving underwriting and investment dynamics. Key players like Kemper, Root, Selective, Travelers, and CNA highlight trends in revenue growth, EPS performance, and stock movements.

Atlantic American (AAME) stock surges 24.5% intraday, driven by a technical breakout with key indicators signaling bullish momentum in the insurance sector niche.

The Progressive Corporation declares a $0.10 per share dividend for Q4 2025, with active insider and institutional trading reflecting market confidence. Analysts maintain positive price targets on PGR stock.

Wall Street sets cautious price targets on Kratos, Trimble, and Selective Insurance Group amid market volatility and tariff impacts. Analyze valuation ratios and market recovery trends relevant to insurance professionals.

Cigna Group navigates rising medical costs, specialty drug expenses, and mixed trading signals as analysts maintain a positive outlook amid sector-wide challenges.

UnitedHealth Group stock falls amid CMS regulatory changes and DOJ probe, presenting high volatility for investors. Insight into earnings impact and market outlook.

F&G Annuities & Life reports 48% drop in short interest, notable insider purchases, and mixed quarterly earnings impact. Analysis of stock performance and institutional ownership trends.

April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.